Skip to content
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Rho Phyto
Trunerox™
Education
MyMedi.ca
Contact
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Rho Phyto
Trunerox™
Education
MyMedi.ca
Contact
Instagram
Twitter
Linkedin
Linkedin
Twitter
Instagram
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Rho Phyto
Trunerox™
Education
MyMedi.ca
Contact
×
About
About
People
Investors
Investor Relations
News and Press
Portfolio
Rho Phyto
Trunerox™
Education
MyMedi.ca
Contact
Avicanna Announces the Canadian Launch of 10% CBD (THC Free) Proprietary Formulation
27 March 2024
Avicanna To Hold Full Year 2023 Earnings Conference Call
26 March 2024
Avicanna Hosts Symposium on Cannabinoid-based Medicine
29 February 2024
Avicanna Announces New Research Collaboration with a Multi-national European-based Pharmaceutical Company
15 February 2024
Avicanna Obtains Its First Indication-Specific Drug Registration with Trunerox™
13 February 2024
Avicanna Announces Supply and Licensing Agreement with Multinational Pharmaceutical Company
5 February 2024
« Prev
1
2
3
4
5
6
7
Next »